Oncological radiology

Our Expertise

Oncological radiology

In the period from now until the year 2030, the number of cancer cases in Germany is expected to at least double. Simultaneously, knowledge about the different types of tumours is rapidly increasing. Knowledge of genetic sequencing and types of treatment that depend on such is as important as the correct initial identification of the tumour and its grade, so that the most appropriate treatment for each individual patient can be initiated.

The crucial role of oncological radiologists
Oncological radiologists play a pivotal role in this process: identifying tumours as soon as possible in the case of nonspecific complaints, correctly diagnosing the type of tumour present, and the accurate characterisation of all possible metastases are all central prerequisites for the correct treatment strategy and, as such, are absolutely crucial to the survival of the patient.

In the oncological network of oncology, surgery and radiotherapy, the radiologist is the central point of contact from initial diagnosis to later follow-up.

Radiologe Prof. Dr. Lars Grenacher

Expertise plays a part in prognosis

Medical imaging in the context of cancer requires comprehensive knowledge in the constantly evolving field of new treatments. Alongside this, the control of recurrences and the review of response to treatments plays a key role and can lead to serious misdiagnoses or overlooked results by radiologists inexperienced in the field of oncology, having a significant negative effect on patient survival.

The advantages are clear

Professor Grenacher has an internationally renowned reputation in this very field and a professional network of national and international cancer specialists.

Early diagnosis as well as the initial characterisation of tumours, therapy control and the detection of recurrences are performed by Grenacher and his team in a conscientious and highly professional manner, and have lead to Conradia Radiologie München’s (ex. Diagnostik München) esteemed reputation which extends far beyond Munich’s city limits.

Where to go in the case of rare tumour types?

Some patients with nonspecific complaints have a string of doctor’s visits behind them. It’s not uncommon for patients to have seen 10-15 doctors without success, and with increasing despair!

Professor Grenacher has extensive diagnostic knowledge in the field of rare tumour diagnostics in particular and can draw on his excellent network for further treatments.